You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美新冠疫苗生產商Moderna舵手料疫情一年內完結
阿思達克 09-24 11:32
美國新冠疫苗生產商Moderna(MRNA.US)行政總裁Stephane Bancel接受瑞士《新蘇黎世報》訪問時預期,隨着疫苗供應增加,新冠疫情可在一年內完結。他預計明年中便有足夠疫苗供全球所有人接種,加強劑亦足夠予有需要人士使用,嬰兒亦可接種疫苗。他又認爲,基於Delta變種高度傳染性,未接種疫苗人士亦將自然地免疫,最終形成與流感相似情況。 Bancel預期各國政府將批準接種第三劑疫苗,因爲去年秋季已接種疫苗人士要接種第三劑疫苗。由於第三劑疫苗劑量只需原來的一半,意味可有更多第三劑疫苗供應,來年可供應30億劑第三劑疫苗,多於原來估算的20億劑。 他又表示,公司研發應對Delta變種疫苗已在臨牀測試,該款疫苗將作爲第三劑疫苗基礎。公司亦正測試應對Delta與Beta潛在混合變種的疫苗。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account